https://www.selleckchem.com/pr....oducts/chk2-inhibito
The mean ages were 52.9±6.7 and 59.1±7.7years in the HIVH and HNR studies, respectively. There were fewer incident CVD events in the HNR study than in the HIVH study (CVD_pAD 3.9% vs. 12.1%; CHD 2.1% vs. 7.8%; CVD 3.5% vs. 9.9%). Age- and sex-adjusted CVD risk was greater with increasing FRS, SCORE and asCVD in both cohorts, but the scores performed more accurately in the HNR than in HIVH study (AUCs FRS 0.71 vs. 0.65; SCORE 0.70 vs. 0.62; asCVD 0.74 vs. 0.62). Associations between risk scores and future CVD were observ
Like
Comment
Share
